Published in Haematologica on October 17, 2006
PRDM1 is required for mantle cell lymphoma response to bortezomib. Mol Cancer Res (2010) 0.86
Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas. Pathogens (2012) 0.76
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. Blood (2008) 2.74
Inorganic polyphosphate and specific induction of apoptosis in human plasma cells. Haematologica (2006) 1.93
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders. Haematologica (2012) 1.45
The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells. Clin Cancer Res (2011) 1.28
Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway. Stem Cells (2006) 1.27
Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis (2003) 1.21
Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res (2005) 1.21
Conventional diagnostics in multiple myeloma. Eur J Cancer (2006) 1.20
CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype. Haematologica (2012) 1.14
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression. Haematologica (2008) 1.06
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance. Blood (2011) 1.03
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica (2012) 0.97
Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res Ther (2010) 0.96
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas. Cancer (2009) 0.95
Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement. Eur J Haematol (2012) 0.95
Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies. Blood (2007) 0.93
Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells. Haematologica (2012) 0.93
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma. Eur J Haematol (2009) 0.93
Human BSAP and BLIMP1 conform an autoregulatory feedback loop. Blood (2007) 0.92
Genomic analysis of high-risk smoldering multiple myeloma. Haematologica (2012) 0.90
Transcription of PRDM1, the master regulator for plasma cell differentiation, depends on an SP1/SP3/EGR-1 GC-box. Eur J Immunol (2008) 0.90
Response to imatinib mesylate in patients with hypereosinophilic syndrome. Int J Hematol (2012) 0.89
Overexpression of the VAV proto-oncogene product is associated with B-cell chronic lymphocytic leukaemia displaying loss on 13q. Br J Haematol (2006) 0.89
Determinants of the anesthetic sensitivity of neuronal nicotinic acetylcholine receptors. J Biol Chem (2001) 0.87
The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells. Haematologica (2007) 0.87
Higher maturity and connective tissue association distinguish resident from recently generated human tonsil plasma cells. J Leukoc Biol (2007) 0.86
Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res (2007) 0.85
STAT-3 activation by differential cytokines is critical for human in vivo-generated plasma cell survival and Ig secretion. J Immunol (2013) 0.85
Chemokine receptor expression on infiltrating lymphocytes from abdominal aortic aneurysms: role of CXCR4-CXCL12 in lymphoid recruitment. Atherosclerosis (2008) 0.85
Transcription factors NF-Y and Sp1 are important determinants of the promoter activity of the bovine and human neuronal nicotinic receptor beta 4 subunit genes. J Biol Chem (2001) 0.84
A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Inflamm Bowel Dis (2005) 0.84
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials. Am J Pathol (2012) 0.84
The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma. Haematologica (2004) 0.84
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. PLoS One (2012) 0.83
Identification of soluble N-ethylmaleimide-sensitive factor attachment protein receptor exocytotic machinery in human plasma cells: SNAP-23 is essential for antibody secretion. J Immunol (2005) 0.83
Cutting edge: IL-21 derived from human follicular helper T cells acts as a survival factor for secondary lymphoid organ, but not for bone marrow, plasma cells. J Immunol (2012) 0.82
Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients. Haematologica (2010) 0.82
BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia. Br J Haematol (2008) 0.82
New tools for diagnosis and monitoring of multiple myeloma. Am Soc Clin Oncol Educ Book (2013) 0.81
Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas. PLoS One (2011) 0.81
CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints. Rheumatology (Oxford) (2006) 0.81
Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain. Leuk Res (2006) 0.80
Differences in thyroid-infiltrating B lymphocytes in patients with Graves' disease: relationship to autoantibody detection. Thyroid (2004) 0.79
In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions. BMC Genomics (2007) 0.79
Persistent polyclonal B lymphocytosis: an expansion of cells showing IgVH gene mutations and phenotypic features of normal lymphocytes from the CD27+ marginal zone B-cell compartment. Br J Haematol (2002) 0.79
Syntaxin-4 is implicated in the secretion of antibodies by human plasma cells. J Leukoc Biol (2013) 0.78
Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression. Pharmacogenet Genomics (2012) 0.78
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response. Haematologica (2011) 0.78
Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies. Cancer Genet Cytogenet (2004) 0.77
NOA36 protein contains a highly conserved nucleolar localization signal capable of directing functional proteins to the nucleolus, in mammalian cells. PLoS One (2013) 0.77
Humoral immunodeficiency in chronic lymphocytic leukemia: role of CD95/CD95L in tumoral damage and escape. Leuk Lymphoma (2002) 0.77
Chromosomal abnormalities are related to location and grade of osteoarthritis. Osteoarthritis Cartilage (2004) 0.77
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma. Br J Haematol (2013) 0.76
Modulated selection of IGHV gene somatic hypermutation during systemic maturation of human plasma cells. J Leukoc Biol (2009) 0.76
Differential expression of SLAMS and other modulatory molecules by human plasma cells during normal maturation. Immunol Lett (2010) 0.75
Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11. Cancer Genet Cytogenet (2005) 0.75
Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme. Ann Surg Oncol (2012) 0.75
X-linked Lymphoproliferative Disease Type 1 in a Patient With the p.Gly93Asp SH2D1A Gene Mutation and Hemophagocytic Lymphohistiocytosis. J Pediatr Hematol Oncol (2017) 0.75
Transient t(11;17)(q14;q12) in patient with chronic myelogenous leukemia in complete molecular response. Cancer Genet Cytogenet (2008) 0.75